Micardis: Effective Blood Pressure Control for Cardiovascular Health
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.74 | $52.19 (0%) | 🛒 Add to cart |
| 60 | $1.34 | $104.37 $80.29 (23%) | 🛒 Add to cart |
| 90 | $1.19 | $156.56 $107.39 (31%) | 🛒 Add to cart |
| 120 | $1.12 | $208.75 $134.48 (36%) | 🛒 Add to cart |
| 180 | $1.05 | $313.12 $189.68 (39%) | 🛒 Add to cart |
| 270 | $1.01 | $469.68 $273.98 (42%) | 🛒 Add to cart |
| 360 | $0.99
Best per pill | $626.25 $357.28 (43%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.48 | $74.27 (0%) | 🛒 Add to cart |
| 60 | $1.96 | $148.53 $117.42 (21%) | 🛒 Add to cart |
| 90 | $1.80 | $222.80 $161.58 (27%) | 🛒 Add to cart |
| 120 | $1.70 | $297.07 $203.73 (31%) | 🛒 Add to cart |
| 180 | $1.62 | $445.60 $291.04 (35%) | 🛒 Add to cart |
| 270 | $1.56 | $668.40 $420.51 (37%) | 🛒 Add to cart |
| 360 | $1.53
Best per pill | $891.20 $549.97 (38%) | 🛒 Add to cart |
Synonyms | |||
Micardis (telmisartan) is an angiotensin II receptor blocker (ARB) prescribed for the management of hypertension in adults. It works by blocking the action of certain natural substances that tighten blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently. This medication helps to lower high blood pressure, which may reduce the risk of strokes, heart attacks, and kidney problems. It is often used when a patient cannot tolerate ACE inhibitors or requires a specific antihypertensive approach tailored to their cardiovascular profile.
Features
- Active ingredient: Telmisartan
- Medication class: Angiotensin II receptor blocker (ARB)
- Available in tablet form: 20 mg, 40 mg, 80 mg strengths
- Once-daily dosing for consistent 24-hour coverage
- Bioavailability of approximately 42%
- Half-life of approximately 24 hours
- Excretion primarily via feces
Benefits
- Provides effective and sustained reduction in systolic and diastolic blood pressure.
- Lowers the risk of major cardiovascular events such as stroke and myocardial infarction.
- May offer renal protective benefits, particularly in hypertensive patients with type 2 diabetes and documented organ damage.
- Supports overall vascular health by improving endothelial function.
- Convenient once-daily dosing supports adherence and consistent therapeutic coverage.
- Generally well-tolerated with a low incidence of side effects like cough compared to ACE inhibitors.
Common use
Micardis is primarily indicated for the treatment of essential hypertension in adults. It may be used as monotherapy or in combination with other antihypertensive agents, such as thiazide diuretics (e.g., hydrochlorothiazide), for additive blood pressure-lowering effects. In some cases, it is also utilized for cardiovascular risk reduction in patients unable to tolerate ACE inhibitors, though this is an off-label application requiring careful clinical judgment.
Dosage and direction
The recommended starting dose of Micardis is 40 mg taken orally once daily. Blood pressure response is dose-related over the range of 20–80 mg. For patients requiring further blood pressure reduction, the dose may be increased to 80 mg once daily. Alternatively, a diuretic may be added. Dosing may be initiated with 20 mg in patients with hepatic impairment. It can be taken with or without food. Consistency in daily timing is advised to maintain stable plasma concentrations.
Precautions
- Monitor renal function and electrolytes periodically, especially in patients with renal impairment, heart failure, or those on concomitant diuretics.
- Use with caution in patients with hepatic impairment; consider lower starting dose.
- Avoid use during pregnancy due to potential risk of fetal injury or death.
- Observe for symptomatic hypotension, particularly in volume-depleted patients (e.g., those on high-dose diuretics).
- Angioedema has been reported; discontinue immediately if it occurs.
- Dual blockade of the renin-angiotensin system (e.g., with an ACE inhibitor) increases risks of hypotension, hyperkalemia, and renal impairment.
Contraindications
- Hypersensitivity to telmisartan or any component of the product.
- Concomitant use with aliskiren in patients with diabetes.
- Pregnancy, especially second and third trimesters.
Possible side effects
Common side effects may include dizziness, upper respiratory tract infection, back pain, sinusitis, and diarrhea. Less frequently, patients may experience hypotension, hyperkalemia, renal impairment, angioedema, or elevated liver enzymes. Rare but serious side effects include rhabdomyolysis and severe cutaneous adverse reactions. Most adverse reactions are mild and transient.
Drug interaction
- Potassium supplements or potassium-sparing diuretics: increased risk of hyperkalemia.
- NSAIDs: may reduce antihypertensive effect and worsen renal function.
- Lithium: increased lithium concentrations and toxicity.
- Digoxin: increased digoxin peak plasma concentration.
- Ramipril: increased risk of adverse effects such as hyperkalemia and renal impairment.
- Aliskiren: contraindicated in patients with diabetes due to increased risk of renal impairment, hyperkalemia, and hypotension.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next dose, skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one.
Overdose
The most likely manifestation of overdose is hypotension and tachycardia. Bradycardia could occur from parasympathetic (vagal) stimulation. If overdose occurs, provide supportive treatment including intravenous normal saline. Telmisartan is not removed by hemodialysis.
Storage
Store at room temperature (20–25°C or 68–77°F), in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and to address any health concerns or conditions. Do not initiate, adjust, or discontinue any medication without medical supervision.
Reviews
Clinical studies and post-marketing surveillance indicate that Micardis is effective in reducing blood pressure with a favorable tolerability profile. Many patients report satisfactory control of hypertension and appreciate the once-daily convenience. Some note dizziness during the initial treatment phase, which often resolves. Healthcare providers frequently regard it as a reliable option within the ARB class, particularly for patients who experience cough with ACE inhibitors. Long-term data support its role in cardiovascular risk modification, though individual responses may vary.